Abstract:In this work, the interaction between different chloro-substituted phenylurea herbicides (diuron (DIU) and chlortoluron (CHL)) and BSA were investigated and compared at three different temperatures (283 K, 298 K and 310 K) adopting UV-vis, fluorescence, and circular dichroism spectra. The quenching mechanism of the interaction was also proposed. The energy transfer between BSA and DIU/CHL was investigated. The binding sites of DIU/CHL and BSA and the variations in the microenvironment of amino acid residues were studied. The changes of the secondary structure of BSA were analyzed. The results indicate that both DIU and CHL can significantly interact with BSA, and the degree of the interaction between DIU/CHL and BSA increases with the increase of the DIU/CHL concentration. The fluorescence quenching of BSA by DIU/CHL results from the combination of static and dynamic quenching. The DIU/CHL has a weak to moderate binding affinity for BSA, and the binding stoichiometry is 1:1. Their binding processes are spontaneous, and hydrophobic interaction, hydrogen bonds and van der Waals forces are the main interaction forces. DIU/CHL has higher affinity for subdomain IIA (Site I) of BSA than subdomain IIIA (Site II), and also interacts with tryptophan more than tyrosine residues. The energy transfer can occur from BSA to DIU/CHL. By comparison, the strength of the interaction of DIU-BSA is always greater than that of CHL-BSA, and DIU can destroy the secondary structure of BSA molecules greater than CHL and thus the potential toxicity of DIU is higher due to DIU with more chlorine substituents than CHL. It is expected that this study on the interaction can offer in-depth insights into the toxicity of phenylurea herbicides, as well as their impact on human and animal health at the molecular level.

Interaction of Diuron to Human Serum Albumin: Insights from Spectroscopic and Molecular Docking Studies.

The Interaction of Dihydromyricetin with Human Serum Albumin by Spectroscopic Methodologies and Molecular Docking

Interaction of different chloro-substituted phenylurea herbicides (diuron and chlortoluron) with bovine serum albumin: Insights from multispectral study

Comparative Interactions of Dihydroquinazolin Derivatives with Human Serum Albumin Observed Via Multiple Spectroscopy

Spectroscopic Studies on the Interaction between Sulfadiazine and Human Serum Albumin

Comparative Studies of Interactions Between Fluorodihydroquinazolin Derivatives and Human Serum Albumin with Fluorescence Spectroscopy

Study on the Interaction Between Daidzein and Human Serum Albumin

Interactions between Human Serum Albumin and Sulfadimethoxine Determined Using Spectroscopy and Molecular Docking

Impact of halogen substituents on interactions between 2-phenyl-2,3-dihydroqulinazolin-4(1H)-one derivatives and human serum albumin.

Study of the Interaction of Aglycon of Daunorubicin with Human Serum Albumin by Spectroscopy and Modeling

Interactions Between Tetrahydroisoindoline-1,3-dione Derivatives and Human Serum Albumin Via Multiple Spectroscopy Techniques

Investigation the Interaction of Daphnin with Human Serum Albumin Using Optical Spectroscopy and Molecular Modeling Methods.

Interaction of Tetrandrine with Human Serum Albumin: a Fluorescence Quenching Study

Spectroscopic Studies of the Interaction of Anti-Coagulant Rodenticide Diphacinone with Human Serum Albumin

Probing the intermolecular interactions into serum albumin and anthraquinone systems: a spectroscopic and docking approach

Fluorescence and Circular Dichroism Studies of Conjugates Between Metsulfuron-Methyl and Human Serum Albumin

Complex of nicosulfuron with human serum albumin: A biophysical study

Investigations of Interaction Mechanism and Conformational Variation of Serum Albumin Affected by Artemisinin and Dihydroartemisinin.

Characterization of the Interactions of Human Serum Albumin with Carmine and Amaranth Using Multi-Spectroscopic Techniques and Molecular Docking

Spectroscopic Studies on Binding of Puerarin to Human Serum Albumin

Specific interaction of 4'-O-(a-l-Cladinosyl) daunorubicin with human serum albumin: The binding site II on HSA molecular using spectroscopy and modeling.